Navigation Links
Second genetic link to weight and obesity
Date:5/4/2008

A study of 90,000 people has uncovered new genetic variants that influence fat mass, weight and risk of obesity. The variants act in addition to the recently described variants of the FTO gene: adults carrying variants in both genes are, on average, 3.8 kg (or 8.5 lb) heavier.

The variants map close to a gene called MC4R: mutations in this gene are the most common genetic cause of severe familial obesity. The study highlights the power of large collections of volunteer samples to uncover common variants that influence health.

"By working together with many international groups we have been able to assemble a sample collection which was large enough to allow this finding to be made," explains Dr Ruth Loos, leading author from the Medical Research Council Epidemiology Unit. "Several groups had shown that rare, highly disruptive variants in the MC4R gene were responsible for very severe, genetic forms of obesity: this collaboration has uncovered more common variants that affect more people."

The study, published in Nature Genetics, is led by investigators from the Cambridge GEM consortium (Genetics of Energy Metabolism) and Oxford University and is a collaboration between 77 institutions from the UK, USA, France, Germany, Italy, Finland and Sweden.

The team studied more than 77,000 adults and found that two copies of genetic variants resulted in an average increase in weight of about 1.5 kg.

This is the second set of common variants that are associated with weight and obesity, following the study, involving many of the same team, published in April 2007 that uncovered a role for the FTO gene. People who carry two copies of an FTO variant are about 2-3 kg heavier than those who have no copies of the variant.

Importantly, the effects of the new gene add to those of FTO; people who carried both the FTO variant and new variants were on average 3.8 kg (8.5 lb) heavier.

"This is a great example of how coope
'/>"/>

Contact: Don Powell
don@sanger.ac.uk
44-012-234-96928
Wellcome Trust Sanger Institute
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. 60 second test could help early diagnosis of common brain diseases
2. BIO-key Reports Second Quarter 2007 Results
3. Communication Intelligence Corporation Reports Second Quarter 2007 Financial Results
4. Weight gain between first and second pregnancies associated with increased odds of male second child
5. Decisions on the second round of the Excellence Initiative announced
6. Does the desire to consume alcohol and tobacco come from our genetic makeup?
7. Diverse genetic abnormalities lead to NF-κB activation in multiple myeloma
8. Many parents at-risk for cancer disclose genetic test results to children
9. Genetics determine optimal drug dose of common anticoagulant
10. Claims of sex-related differences in genetic association studies often not properly validated
11. American College of Medical Genetics responds to new FDA labeling decision for warfarin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015   ... medication safety systems and image documentation solutions ... of comprehensive, technologically-advanced automation solutions, is pleased ... integration. The Codonics® Safe Label System® (SLS), ... in conjunction with the Omnicell Anesthesia Workstation, ...
(Date:5/22/2015)... Inc. (NASDAQ: NXTD ) ("NXT-ID" or the "Company") announces ... pricing and making the Wocket generally available for $229 via ... of Marketing said, "We,ve extended the opportunity to take advantage ... To get your wocket at this special price, submit your ... June 1, you,ll receive a unique code that gives you ...
(Date:5/21/2015)... The Sync Project™ , a global collaboration harnessing ... a collaborative partnership with Berklee,s Institute for Creative ... on original research, joint course development and an internship ... Sync Project and BerkleeICE are exploring the launch of ... academic year.  The course will focus ...
Breaking Biology News(10 mins):Codonics and Omnicell Expand Partnership 2Codonics and Omnicell Expand Partnership 3Codonics and Omnicell Expand Partnership 4NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 2NXT-ID, Inc Announces Retail Price For Wocket Smart Wallet And Extends Discounted Promotional Price Till End Of May 3The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 2The Sync Project Announces Partnership with Berklee College of Music's Institute for Creative Entrepreneurship 3
... has resulted in a design for high tech polyvalent rescue ... immediately carry up to four patients away for treatment. The ... of four-stretcher support that can be installed in different vehicles. ... adapted to a range of vehicles while offering weight reductions ...
... Scientists at Burnham Institute for Medical Research (Burnham) have ... major role in promoting programmed cell death (apoptosis), helps relay ... invade surrounding tissues. The study was published in the journal ... of scientists, led by Kristiina Vuori, M.D., Ph.D., professor and ...
... reports last week about scuba divers off San Diego being ... raised the ire of University of Rhode Island biologist Brad ... has dived with them several times, he calls the reports ... For years Seibel has heard stories claiming that Humboldt ...
Cached Biology News:High-tech vehicle design boosts emergency rescue capacity 2High-tech vehicle design boosts emergency rescue capacity 3Protein that promotes cancer cell growth identified 2URI researcher sheds light on 'man-eating' squid; finds them timid, non-threatening 2URI researcher sheds light on 'man-eating' squid; finds them timid, non-threatening 3
(Date:6/2/2015)... , June 2, 2015 /PRNewswire/ -- China Cord Blood Corporation (NYSE: ... China,s leading provider of cord blood ... storage services, today announced that the Special Committee of the ... Houlihan Lokey ( China ) Limited as ... Hamilton LLP as its United States ...
(Date:6/2/2015)... June 2, 2015 MGB ... antibiotic resistance problem  MGB Biopharma, a ... anti-infectives, to address the major global problem of ... a stable intravenous (IV) formulation of MGB-BP-3, designed for ... infections.  The intravenous formulation of MGB-BP-3 ...
(Date:6/1/2015)... , June 1, 2015  Turing Pharmaceuticals ... Eliseo Oreste Salinas , MD, MSc,  has joined ... Dr. Salinas, who holds a medical ... brings a record of significant accomplishments in the ... Dr. Salinas has played a leadership ...
(Date:6/1/2015)... CHICAGO , June 1, 2015 /PRNewswire/ ... robust Decipher® genomic analysis platform, successfully classified ... the genomic expression of certain biomarkers, including ... chemotherapy. Importantly, this unique genomic signature has ... responsiveness to neoadjuvant chemotherapy in patients with ...
Breaking Biology Technology:China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 3MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 3Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 2GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 3GenomeDx's Decipher Platform Validates Genomic Signature that may Predict Resistance to Chemotherapy in Bladder Cancer Patients in Study Presented at ASCO 2015 Annual Meeting 4
... The Board of,Directors of Shire plc (LSE: SHP, ... announces today that David Mott will,join the Board ... Mr Mott is Chief Executive Officer and ... to in 2000. He joined MedImmune in 1992 ...
... ... Data, VANCOUVER ... a clinical-stage developer of drugs for infectious,diseases will present at the Acumen ... York Palace Hotel in New York,NY on November 5-7, 2007. Jim DeMesa, ...
... Oct. 31 Amedica Corporation,an orthopedic implants company ... the U.S. Food and Drug Administration,has granted 510(k) ... The Valeo(TM) Cervical Plate system combines features aimed ... The,Valeo(TM) Cervical Plate system is intended for anterior ...
Cached Biology Technology:David Mott Appointed Non Executive Director at Shire 2David Mott Appointed Non Executive Director at Shire 3MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 2MIGENIX to Present at the Acumen BioFin Rodman & Renshaw 9th Annual Healthcare Conference 3
... Collect eliminates manual data entry by collecting ... any Windows-based application. Collect is extremely ... hours of tedious data entry. An ... scales, pH meters, spectrophotometers, force gauges, digital ...
Mouse monoclonal [5H9] to RAD52 ( Abpromise for all tested applications). entrezGeneID: 5893 SwissProtID: P43351...
Purified anti-LAT...
Cytosol/Particulate Rapid Separation Kit Research Focus: other Storage Temperature: -20C Shipping Temperature: 4C...
Biology Products: